echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Do we need a new diagnosis of "acute anxiety disorder"?

    Do we need a new diagnosis of "acute anxiety disorder"?

    • Last Update: 2023-01-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    Compiled by Yimaitong, please do not reprint
    without authorization.

    Patient F, a 42-year-old male, complains that he has always been a very anxious person who has a great
    impact on daily life.
    Even so, Mr.
    F's anxiety has reached unprecedented levels over the past month: as a result of taking on a new job assignment and his son's diagnosis of lupus, he has developed into a "24-hour, 7-day-a-week" worry
    This concern has made it difficult for Mr.
    F to focus on his work and is planning to call in sick

    F's wife reported that she was also frustrated
    to see Mr.
    F isolating himself from family and friends.
    F himself acknowledges the above facts and attributes them to overwhelming anxiety

    F has chronic anxiety, muscle tone, and anxiety-related irritability, all of which have worsened
    significantly in the last month.
    F admits that he occasionally wonders recently whether he would be more relaxed if he didn't live, but denied that there were problems with energy or motivation, saying that he was just very anxious and not depressed
    F drinks one glass of wine a week, but has no other substance use problems; Overweight with slightly elevated cholesterol but no other serious physical problems; Melatonin products used to aid sleep, without prescription medications

    "Acute anxiety disorder"?

    Based on the limited information above, Mr.
    F appears to be experiencing a worsening
    of chronic generalized anxiety disorder (GAD).
    However, the authors propose a new diagnostic concept, called "acute anxiety disorder
    " This term covers acute exacerbations of anxiety disorders that are already suffered, with GAD or panic disorder being more common

    The proposed diagnostic criteria for "acute anxiety disorder" proposed by the authors are as follows:

    Extreme anxiety persists for ≥ 2 weeks, significantly changed
    from baseline.

    Anxiety symptoms cause significant social, occupational, and/or other important areas of functional impairment

    An anxiety attack is a worsening
    of an anxiety disorder that is already suffered.

    Anxiety attacks cannot be directly attributed to the physiological effects of a substance or to a physical illness

    Anxiety episodes cannot be better explained
    by the presence of psychotic disorders.

    There is already such a statement as "acute exacerbation of chronic anxiety disorder", why is there still the concept of "acute anxiety disorder", is it redundant? In the author's view, this new concept can suggest that patients are experiencing a sharp deterioration in baseline function, which is meaningful for emphasizing the severity of the disease, guiding treatment, and follow-up research.

    Severity of the disease

    Anxiety disorders, such as GAD, although they are deeply disturbing to many patients, are often not considered a serious category of diseases
    in traditional beliefs.
    A diagnosis of "acute anxiety disorder" can isolate the patient's current state from a relatively mild chronic condition – the patient is going through a difficult special period in which functional impairment is quite severe
    Of course, "acute anxiety disorder" will not turn anxiety into a serious illness such as the possibility of applying for long-term subsidies, but it is expected to bring short-term convenience
    to patients in difficulty.


    At present, the mainstream treatment for anxiety disorders is SSRIs and SNRIs antidepressants
    However, these drugs can cause transient anxiety exacerbations early in use, and patients with acute anxiety are particularly sensitive to these side effects and therefore need to be increased
    This may be different from other anxious patients
    At the same time, given the overall slow onset of response to SSRIs and SNRIs, the treatment of patients with "acute anxiety disorder" may be possible to go beyond the usual and use drugs that act faster, such as benzodiazepines or sedative sleep aids (eg, zolpidem), but also need to take into account the risks
    In addition, although neither mirtazapine nor pregabalin have formal indications for anxiety, they have a relatively rapid onset of action and can improve both anxiety and sleep, and can be considered
    if necessary.


    In patients with acute anxiety, it is necessary to assess which treatments are more effective, and to try to develop relevant psychotherapies
    Some evidence suggests that esketamine or ketamine may be effective for this condition and can be further investigated

    Source: Adriel Gerard, MD.
    Proposal for a new diagnosis: Acute anxiety disorder.
    Current Psychiatry.
    2022 September; 21(9):e1-e3 | doi: 10.

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.